|
Name |
Hamisonine
|
Molecular Formula | C26H32O10 | |
IUPAC Name* |
7-(2,3-dihydrofuran-4-yl)-18,19-dihydroxy-19-methoxy-1,8,12,17-tetramethyl-3,6,16-trioxapentacyclo[9.9.0.02,4.02,8.012,18]icos-13-ene-5,15,20-trione
|
|
SMILES |
COC1(O)C(=O)C2(O)C(C)OC(=O)C=CC2(C)C2CCC3(C)C(C4=COCC4)OC(=O)C4OC43C21C
|
|
InChI |
InChI=1S/C26H32O10/c1-13-24(30)20(29)26(31,32-5)23(4)15(21(24,2)10-7-16(27)34-13)6-9-22(3)17(14-8-11-33-12-14)35-19(28)18-25(22,23)36-18/h7,10,12-13,15,17-18,30-31H,6,8-9,11H2,1-5H3/t13-,15?,17?,18?,21-,22?,23-,24?,25?,26?/m1/s1
|
|
InChIKey |
MGUZDFKJDHKVOZ-KSWYYIDFSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 504.53 | ALogp: | 0.9 |
HBD: | 2 | HBA: | 10 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 141.1 | Aromatic Rings: | 6 |
Heavy Atoms: | 36 | QED Weighted: | 0.322 |
Caco-2 Permeability: | -5.299 | MDCK Permeability: | 0.00001150 |
Pgp-inhibitor: | 0.996 | Pgp-substrate: | 0.014 |
Human Intestinal Absorption (HIA): | 0.04 | 20% Bioavailability (F20%): | 0.971 |
30% Bioavailability (F30%): | 0.925 |
Blood-Brain-Barrier Penetration (BBB): | 0.993 | Plasma Protein Binding (PPB): | 49.09% |
Volume Distribution (VD): | 1.437 | Fu: | 54.16% |
CYP1A2-inhibitor: | 0.006 | CYP1A2-substrate: | 0.956 |
CYP2C19-inhibitor: | 0.049 | CYP2C19-substrate: | 0.748 |
CYP2C9-inhibitor: | 0.062 | CYP2C9-substrate: | 0.006 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.067 |
CYP3A4-inhibitor: | 0.696 | CYP3A4-substrate: | 0.942 |
Clearance (CL): | 3.633 | Half-life (T1/2): | 0.036 |
hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.173 |
Drug-inuced Liver Injury (DILI): | 0.163 | AMES Toxicity: | 0.827 |
Rat Oral Acute Toxicity: | 0.982 | Maximum Recommended Daily Dose: | 0.935 |
Skin Sensitization: | 0.054 | Carcinogencity: | 0.947 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.015 |
Respiratory Toxicity: | 0.954 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003376 | 0.343 | D0I5DS | 0.267 | ||||
ENC005317 | 0.333 | D0G6AB | 0.260 | ||||
ENC005189 | 0.333 | D0P0HT | 0.259 | ||||
ENC003107 | 0.331 | D02JNM | 0.259 | ||||
ENC002987 | 0.331 | D0IL7L | 0.252 | ||||
ENC005188 | 0.319 | D0D2TN | 0.248 | ||||
ENC005318 | 0.319 | D03HYX | 0.245 | ||||
ENC002577 | 0.313 | D0IT2G | 0.245 | ||||
ENC003282 | 0.309 | D0CW1P | 0.245 | ||||
ENC002849 | 0.301 | D07DVK | 0.245 |